159 related articles for article (PubMed ID: 16622901)
1. Population-based study of prognostic factors in stage II colonic cancer.
Morris M; Platell C; de Boer B; McCaul K; Iacopetta B
Br J Surg; 2006 Jul; 93(7):866-71. PubMed ID: 16622901
[TBL] [Abstract][Full Text] [Related]
2. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
3. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
Gertler R; Rosenberg R; Schuster T; Friess H
Eur J Cancer; 2009 Nov; 45(17):2992-9. PubMed ID: 19682890
[TBL] [Abstract][Full Text] [Related]
4. Young age is not a poor prognostic marker in colorectal cancer.
Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F
Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
6. Surgical volume influences survival in patients undergoing resections for stage II colon cancers.
Morris M; Platell CF
ANZ J Surg; 2007 Oct; 77(10):902-6. PubMed ID: 17803560
[TBL] [Abstract][Full Text] [Related]
7. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
9. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
[TBL] [Abstract][Full Text] [Related]
10. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
[TBL] [Abstract][Full Text] [Related]
11. S-phase fraction can predict event free survival in patients with pT2-T3N0M0 colorectal carcinoma: implications for adjuvant chemotherapy.
Cascinu S; Ligi M; Graziano F; Del Ferro E; Valentini M; Grianti C; Bartolucci M; Catalano G
Cancer; 1998 Sep; 83(6):1081-5. PubMed ID: 9740071
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer.
Biondo S; Martí-Ragué J; Kreisler E; Parés D; Martín A; Navarro M; Pareja L; Jaurrieta E
Am J Surg; 2005 Apr; 189(4):377-83. PubMed ID: 15820446
[TBL] [Abstract][Full Text] [Related]
14. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C
Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102
[TBL] [Abstract][Full Text] [Related]
17. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment for elderly patients with colon cancer. An observational study.
Pasetto LM; Falci C; Basso U; Gasparini G; D'Andrea M; Bonginelli P; Bajetta E; Platania M; Alabiso O; Miraglia S; Bertona E; Oniga F; Biason R; Chetrì MC; Fedele P; Massara G; Romaniello I; Negru ME; Luchena G; Giordano M; Buzzi F; Ricottao R; Sienao S; Monfardini S
Anticancer Res; 2008; 28(4C):2513-8. PubMed ID: 18751443
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age.
Liang JT; Huang KC; Cheng AL; Jeng YM; Wu MS; Wang SM
Br J Surg; 2003 Feb; 90(2):205-14. PubMed ID: 12555297
[TBL] [Abstract][Full Text] [Related]
20. The number of high-risk factors is related to outcome in stage II colonic cancer patients.
Koebrugge B; Vogelaar FJ; Lips DJ; Pruijt JF; van der Linden JC; Ernst MF; Bosscha K
Eur J Surg Oncol; 2011 Nov; 37(11):964-70. PubMed ID: 21930361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
